Tag: womens
-
Evofem Biosciences Raises $50M In Offering
San Diego-based Evofem Biosciences, a developer of biopharmaceuticals for female reproductive health, reported it raised $50M in its previously announced public offering. It said it will net approximately $46.6M after underwriting discounts, commission…
-
Evofem Prices $50M Offering
San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women’s contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term …